Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27748284
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Indian+J+Med+Res
2016 ; 143
(Supplement
): S104-S111
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Microsatellite instability & survival in patients with stage II/III colorectal
carcinoma
#MMPMID27748284
Srdjan M
; Jadranka A
; Ivan D
; Branimir Z
; Daniela B
; Petar S
; Velimir M
; Zoran K
Indian J Med Res
2016[May]; 143
(Supplement
): S104-S111
PMID27748284
show ga
BACKGROUND & OBJECTIVES: The two key aspects associated with the microsatellite
instability (MSI) as genetic phenomenon in colorectal cancer (CRC) are better
survival prognosis, and the varying response to 5-fluorouracil (5-FU)-based
chemotherapy. This study was undertaken to measure the survival of surgically
treated patients with stages II and III CRC based on the MSI status, the
postoperative 5-FU treatment as well as clinical and histological data. METHODS:
A total of 125 consecutive patients with stages II and III (American Joint
Committee on Cancer, AJCC staging) primary CRCs, were followed prospectively for
a median time of 31 months (January 2006 to December 2009). All patients were
assessed, operated and clinically followed. Tumour samples were obtained for
cytopathological verification and MSI grading. RESULTS: Of the 125 patients, 21
(20%) had high MSI (MSI-H), and 101 patients (80%) had MSI-L or MSS (low
frequency MSI or stable MSI). Patients with MSS CRC were more likely to have
recurrent disease (P=0.03; OR=3.2; CI 95% 1-10.2) compared to those with MSI-H
CRC. Multi- and univariate Cox regression analysis failed to show a difference
between MSI-H and MSS groups with respect to disease-free, disease-specific and
overall survival. However, the disease-free survival was significantly lower in
patients with MSI-H CRC treated by adjuvant 5-FU therapy (P=0.03). INTERPRETATION
& CONCLUSIONS: MSI-H CRCs had a lower recurrence rate, but the prognosis was
worse following adjuvant 5-FU therapy.